Author:
Vahdat L T,Cohen D J,Zipin D,Lo K S,Donovan D,Savage D,Tiersten A,Nichols G,Troxel A,Hesdorffer C S
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference43 articles.
1. Roche H, Viens P, Biron P, Lotz JP, Asselain B . High-dose chemotherapy for breast cancer: the French PEGASE experience. Cancer Control 2003; 10: 42–47.
2. Crown J, Lind M, Gould A, Verrill M, Twelves C, Coleman R et al. High-dose chemotherapy with autograft(PBP) support is not superior to cyclophosphamide, methotrexate and 5-FU following doxorubicin induction in patients with breast cancer and 4 or more involved axillary lymph nodes: the Anglo-Celtic I study. Proc Amer Soc Clin Oncol 2002; 21: 42a (abstract 166).
3. Nitz UA, Mohrmann S, Fischer J, Lindemann W, Berdel WE, Jackisch C et al. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial. Lancet 2005; 366: 1935–1944.
4. Rodenhuis S, Bontenbal M, Beex LV, Wagstaff J, Richel DJ, Nooij MA et al. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med 2003; 349: 7–16.
5. Tallman MS, Gray R, Robert NJ, LeMaistre CF, Osborne CK, Vaughan WP et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. N Engl J Med 2003; 349: 17–26.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献